These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9615263)

  • 41. [Isolation of Helicobacter pylori in gastric mucosa, dental plaque and saliva in a population from the Venezuelan Andes].
    De Sousa L; Vásquez L; Velasco J; Parlapiano D
    Invest Clin; 2006 Jun; 47(2):109-16. PubMed ID: 16886773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammation, immunity, vaccines for Helicobacter infection.
    Chmiela M; Michetti P
    Helicobacter; 2006 Oct; 11 Suppl 1():21-6. PubMed ID: 16925607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Contents of anti-Helicobacter pylori antibodies in digestive system diseases].
    Tsaregorodtseva TM; Serova TI; Gladilina MV; Gubina AV
    Eksp Klin Gastroenterol; 2006; (1):54-8. PubMed ID: 16866247
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies.
    Perri F; Clemente R; Festa V; De Ambrosio CC; Quitadamo M; Fusillo M; Grossi E; Andriulli A
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):290-4. PubMed ID: 10425573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.
    Hoffelner H; Rieder G; Haas R
    Int J Med Microbiol; 2008 Jan; 298(1-2):151-9. PubMed ID: 17714988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.
    Suzuki T; Matsushima M; Masui A; Watanabe K; Takagi A; Ogawa Y; Shirai T; Mine T
    Am J Gastroenterol; 2005 Jun; 100(6):1265-70. PubMed ID: 15929755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A solid-phase enzyme-linked immunospot (ELISPOT) assay for detection of Helicobacter pylori antibody-producing cells in gastric mucosa.
    Sugiyama T; Furuyama S; Awakawa T; Imai K; Yabana T; Yachi A; Yokota K; Oguma K
    Gastroenterol Jpn; 1991 Oct; 26(5):684. PubMed ID: 1752401
    [No Abstract]   [Full Text] [Related]  

  • 48. Decreased Helicobacter pylori-specific gastric secretory IgA antibodies in infected patients.
    Birkholz S; Schneider T; Knipp U; Stallmach A; Zeitz M
    Digestion; 1998; 59(6):638-45. PubMed ID: 9813386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune responses to mucosal infection: the Helicobacter pylori paradigm.
    Ferrero RL
    Res Immunol; 1997 Feb; 148(2):91-107. PubMed ID: 9226764
    [No Abstract]   [Full Text] [Related]  

  • 50. Helicobacter pylori and idiopathic thrombocytopenic purpura.
    Franceschi F; Christodoulides N; Kroll MH; Genta RM
    Ann Intern Med; 2004 May; 140(9):766-7. PubMed ID: 15126268
    [No Abstract]   [Full Text] [Related]  

  • 51. Immune response to H. pylori.
    Suarez G; Reyes VE; Beswick EJ
    World J Gastroenterol; 2006 Sep; 12(35):5593-8. PubMed ID: 17007009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe?
    de Bernard M; D'Elios MM
    Toxicon; 2010 Dec; 56(7):1186-92. PubMed ID: 19818802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathophysiological mechanism of Helicobacter infections--host factors].
    Sugiyama T; Asaka M
    Nihon Naika Gakkai Zasshi; 1998 May; 87(5):813-8. PubMed ID: 9648430
    [No Abstract]   [Full Text] [Related]  

  • 54. [Direct and indirect diagnostic methods for Helicobacter pylori infections].
    Mégraud F
    Gastroenterol Clin Biol; 1994; 18(3):217-22. PubMed ID: 7926436
    [No Abstract]   [Full Text] [Related]  

  • 55. [TLR4/MD -2-dependent recognition of H. pylori LPS during gastric inflammation].
    Ishihara S; Kinoshita Y
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():69-74. PubMed ID: 16363507
    [No Abstract]   [Full Text] [Related]  

  • 56. Bleeding ulcer: diagnosis of Helicobacter pylori infection.
    Buckley M; Dumas R; Maes B; Hastier P; Caroli-Bosc FX; Delmont JP
    Gastrointest Endosc; 1997 Sep; 46(3):287-8. PubMed ID: 9378227
    [No Abstract]   [Full Text] [Related]  

  • 57. Biological marker for diseases sustained by Helicobacter pylori infection.
    Covacci A
    Dig Liver Dis; 2000; 32(5):384-5. PubMed ID: 11030182
    [No Abstract]   [Full Text] [Related]  

  • 58. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.
    Algood HM; Cover TL
    Clin Microbiol Rev; 2006 Oct; 19(4):597-613. PubMed ID: 17041136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric Helicobacter pylori Infection Affects Local and Distant Microbial Populations and Host Responses.
    Kienesberger S; Cox LM; Livanos A; Zhang XS; Chung J; Perez-Perez GI; Gorkiewicz G; Zechner EL; Blaser MJ
    Cell Rep; 2016 Feb; 14(6):1395-1407. PubMed ID: 26854236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens.
    Reiche N; Jung A; Brabletz T; Vater T; Kirchner T; Faller G
    Infect Immun; 2002 Aug; 70(8):4158-64. PubMed ID: 12117924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.